Literature DB >> 26180513

Research Progress of Moyamoya Disease in Children.

Jianmin Piao1, Wei Wu1, Zhongxi Yang1, Jinlu Yu1.   

Abstract

During the onset of Moyamoya disease (MMD), progressive occlusion occurs at the end of the intracranial internal carotid artery, and compensatory net-like abnormal vessels develop in the skull base, generating the corresponding clinical symptoms. MMD can affect both children and adults, but MMD in pediatric patients exhibits distinct clinical features, and the treatment prognoses are different from adult patients. Children are the group at highest risk for MMD. In children, the disease mainly manifests as ischemia, while bleeding is the primary symptom in adults. The pathogenesis of MMD in children is still unknown, and some factors are distinct from those in adults. MMD in children could result in progressive, irreversible nerve functional impairment, and an earlier the onset corresponds to a worse prognosis. Therefore, active treatment at an early stage is highly recommended. The treatment methods for MMD in children mainly include indirect and direct surgeries. Indirect surgeries mainly include multiple burr-hole surgery (MBHS), encephalomyosynangiosis (EMS), and encephaloduroarteriosynangiosis (EDAS); direct surgeries mainly include intra- and extracranial vascular reconstructions that primarily consist of superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis. Indirect surgery, as a treatment for MMD in children, has shown a certain level of efficacy. However, a standard treatment approach should combine both indirect and direct procedures. Compared to MMD in adults, the treatment and prognosis of MMD in children has higher clinical significance. If the treatment is adequate, a satisfactory outcome is often achieved.

Entities:  

Keywords:  Children; Moyamoya disease; prognosis; surgical treatment

Mesh:

Year:  2015        PMID: 26180513      PMCID: PMC4502061          DOI: 10.7150/ijms.11719

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


I. Introduction

MMD was first described in the Japanese literature in 1957 1. During examinations using digital subtraction angiography (DSA), computed tomographic angiography (CTA), and magnetic resonance angiography (MRA), a stenosis or occlusion was discovered at the end of the internal carotid artery, and compensatory abnormal proliferation of the vascular network was observed in the skull base 2. MMD shows two peaks of onset in the human population: one at approximately 40 years of age, which manifests as bleeding during clinical onset, and another at approximately five years of age, which manifests mainly as clinical ischemia, also known as MMD in children 3. The severity of MMD in children is age-related; in younger children, the condition is more severe. Studies have shown that children younger than four years often exhibit poor prognoses in MMD 4. The incidence of MMD shows obvious regional differences. MMD is more commonly observed in Eastern Asian countries, such as Japan, Korea, and China. In Japan, the incidence of MMD is 3-10/100,000, whereas the incidence is 0.09/100,000 in the USA 5. MMD is more common in female patients, and the male to female ratio ranges from 1:1.8 to 1:4.25 6,7. Currently, no specialized literature has reported the epidemiology of MMD in children, but pediatric patients have been included in epidemiological analyses of MMD, which suggests that MMD in children might also be consistent with the epidemiological characteristics described above. The pathogenic mechanism of MMD in children has not been clarified. Based on a review of the relevant literature, the pathogenesis of MMD could be related to genetic, immune, and radiological factors, along with the abnormal expression of angiogenesis factors. In addition to MMD, we also reviewed studies of children with Moyamoya syndrome (MMS) due to the many similarities between MMD and MMS. MMS is often pertinent to many other conditions, such as multiple neurofibromatosis, head radiotherapy, sickle cell anemia, and Down's syndrome 8,9. DSA is the gold standard for MMD diagnosis. However, due to the young age of affected children, the application of DSA is limited. Therefore, many other auxiliary examination methods, such as MRA and CTA, have also been applied. MRA and CTA have high specificities in MMD diagnoses 10. The treatment of children with MMD also has its own characteristics, primarily because the vessels on the brain surface are slender and fragile, and therefore, direct vascular reconstruction is much more difficult in children than in adults. In addition, the blood supply area of the branches of the superficial temporal artery (STA) is limited so that functional cortices are often not covered. Therefore, the application of indirect surgery has been extensive 11. Indirect surgery for children with MMD includes surgeries such as multiple burr-hole surgery (MBHS), encephalomyosynangiosis (EMS) and encephaloduroarteriosynangiosis (EDAS). Previous studies have reported that these procedures demonstrate better effects in children than in adults 12. In fact, no standard treatment plan for children with MMD is currently applied in clinical practice 13.

II. Possible pathogenic mechanisms of MMD in children

The symptoms of children with MMD are primarily the result of progressive vascular stenosis. The histological characteristics of vascular stenosis include fibrointimal hyperplasia, impairment of the elastic layer of the media, and vascular smooth muscle cell proliferation 14. A previous study reported that the small irregular wave-shaped changes at the internal elastic membrane could be regarded as histological characteristics of MMD 15. However, which mechanism results in the discussed pathological changes in children with MMD has yet not been determined. Based on a literature review, the following factors were determined to be influential in the MMD pathogenesis of children.

1. Genetic factors

The genetic influence of MMD is primarily due to its familial distribution. Previous studies have revealed that 10% of MMD cases occur in the same family, and 70% occur in siblings, which involves multiple pediatric patients 16. The genetics of MMD appear to involve a multiple genetic factor principle. Papavasiliou et al. studied the genotypes of two European children with MMD and discovered that the MT3 sequence in the D-loop of the mitochondrial DNA and the Y chromosome gene in these European patients are consistent with the genetic sequences found in Japanese MMD patients. These results indicated that these genes might be correlated with MMD onset 17. HS Kang et al. discovered that the G/C hybrid genotype at position 418 of the TIMP2 promoter is an inducer of familial MMD 18. Sakurai et al. revealed that autosome 8q22.3, which encodes the TIEG genotype, could be the genetic sequence that causes MMD 19. Fujimura et al. found that RNF213 was an important predisposing gene for MMD in eastern Asian children 20. These studies did not exclude childhood MMD cases. Therefore, MMD in children may also include genetic variations, as discussed above. SH Hong et al. showed that, in the children with MMD, the allelic genes of HLA-DRB1*1302 and DQB1*0609 exhibit correlations with MMD occurrence. This study further suggested that a genetic polymorphism in the HLA-Class-II genome was the inducing factor of familial MMD 21. YS Park et al. discovered that the allelic gene of VEGF-634G was related to MMD in children 22. Hitomi et al. found that the RNF213 R4810K mutation induced mitotic abnormalities and increased the risk of genomic instability. Ultimately, its polymorphism could increase susceptibility to MMD, including pediatric MMD 23. Furthermore, the RNF213 R4810K mutation reduced the angiogenic activity of induced pluripotent stem cells (iPSECs) in patients with MMD, suggesting that it may be a promising in vitro model for MMD 24. In a rare case of a mutation of CBL associated with MMD, Hyakuna et al. showed that both NF1 and CBL participate in the RAS/MAPK pathway, indicating a common underlying pathogenesis of MMD 25. Darrigo Júnior LG et al. examined a pediatric patient with multiple neurofibromatosis and discovered that a mutation of the NF-1 gene could stimulate the abnormal protein function of neurofibromatosis, causing vascular smooth muscle cell proliferation and resulting in MMS 26. It is worth noting that due to differences in clinical symptoms observed between children and adults with MMD, the genotypes of the two populations might also be different 27.

2. Abnormal angiogenesis factors

A previous study revealed that vascular endothelial growth factor (VEGF) could be one of the causes of MMD by testing cerebrospinal fluid and blood from MMD patients 28. In addition, Yoshimoto et al. found increased concentrations of basic fibroblast growth factor (bFGF) in cerebrospinal fluid in children with MMD. bFGF could induce vascular endothelial cell, smooth muscle cell, and fibroblast proliferation and angiogenesis, which suggested that bFGF could be a predisposing factor for MMD in children 29. Hojo et al. showed that the serum concentration of transforming growth factor-beta1 (TGFb1) was extremely high in children with MMD. TGFb1 plays an important role in cell proliferation and mutation and regulates the expression of connective tissue genes and angiogenesis, suggesting that childhood-onset MMD may be related to TGFb1 30.

3. Infection immune factors

The human immune response to the invasion of microorganisms has also been suggested to cause MMD 31. Yamada et al. found high levels of Propionibacterium acnes (P. acnes) antibody titers in the sera of MMD patients, suggesting that P. acnes and immune factors may be related to the occurrence of MMD in both children and adults 32. Sharfstein et al. discovered that the human immunodeficiency virus (HIV) could introduce vascular lesions in the brain, which could result in MMD. However, this study only included adult patients. Further study is required to confirm whether HIV infection could result in MMD in children 33. However, Hsiung GY et al. reported a 10-year-old MMD patient in whom the cause of onset was related to congenital HIV infection 34. TK Kim et al. reported an acute necrotizing encephalopathy (ANE) case that occurred on the 24th day after birth, which was cured. Twenty-eight months after birth (27 months after the encephalopathy was cured), the patient suffered from sudden awareness and movement disorders and was diagnosed with childhood-onset MMD after a DSA examination 35. H Li et al. examined 114 childhood-onset MMD cases and found that enhanced thyroid function and increased thyroid autoantibody levels were closely related to MMD development 36. These results suggested that the occurrence of childhood-onset MMD might be pertinent to infections and immune responses.

4. Radiation-inducing factors

Radiation treatment has also been suggested as a factor in the development of childhood-onset MMD. Radiation therapy can degrade both vascular walls and the elastic tissue on the inner walls of blood vessels and can cause occlusions at the end of the internal carotid artery, resulting in MMD 37. Kikuchi et al. discovered that frequent head radiation treatments in acute pediatric patients with lymphoblastic lymphoma could induce MMD 38. Ullrich et al. revealed that radiation treatment for intracranial tumors in children could also result in MMD. In addition, it has been observed that in younger patients that receive higher dosages of radiation, the probability of developing MMD is increased 39. Kestle et al. examined 28 children with optic glioma and found that after receiving radiation treatment, five patients developed MMD after surgery. In contrast, none of the 19 patients who did not receive radiation therapy developed MMD 40. This difference may have been observed because radioactive treatments can result in MMD-like variations in the blood vessels in the brain of patients with affirmative causes. These cases can also be regarded as MMS.

5. Other factors

In addition to the pathogenesis mechanisms discussed above, other studies have also mentioned several pathogenic factors of MMD that are primarily related to MMS. Therefore, it is necessary to define Moyamoya syndrome. It is an MMD-like disease induced by other diseases (such as multiple neurofibromatosis, sickle cell anemia, Down's syndrome, Grave's disease, and hemoglobin Southampton) or adverse factors (such as radiation therapy or chemotherapy) 41,42,43. For example, Buchbinder et al. performed interferon-alpha chemotherapy while treating a 12-year-old osteosarcoma patient and discovered that the patient's intracranial vasculature exhibited serious MMD-like changes. This result suggested that interferon-alpha might be correlated with MMD development 44. Meena SS et al. reported the MRA results of a 3-year-old patient with severe iron deficiency anemia with MMD-like lesions, thus implying a correlation between the pathogeneses of the two diseases 45. Vo Van P et al. reported a 5-year-old patient with hereditary spherocytosis. The patient received an MRA exanimation due to a transient ischemic attack (TIA) and was found to have intracranial MMD-like lesions 46. Ramesh K et al. examined a 14-month-old infant with MMD and suggested that the onset was related to renal agenesis and external iliac artery stenosis. The authors came to the conclusion that the patient had developed MMD while in the uterus 47.

III. Diagnosis of MMD in children

1. Diagnostic criteria

In 1997, the Research Committee on MMD published the first English guidelines for MMD diagnosis and treatment. An MMD diagnosis should satisfy the following three criteria: stenosis or occlusion appears at the end of the internal carotid artery; an abnormal vascular network (known as MMD vasoganglion) is present; and bilateral changes occur 48. The diagnostic criteria for MMD in children are slightly different from those of adults. In children, an MMD diagnosis can be confirmed if a unilateral change is observed. In other words, both unilateral and bilateral changes can be diagnosed as childhood-onset MMD; however, in adult cases of MMD, the changes must be bilateral. If a unilateral MMD-like change is observed in an adult, it can only be diagnosed as possible or unilateral MMD. However, the diagnostic criteria of MMS are the same for both children and adults. Specifically, relevant diseases are confirmed based on the diagnostic criteria discussed above (i.e., risk factors that result in the vascular changes discussed above) 49.

2. Diagnostic methods

The imaging diagnosis and evaluation of children with MMD include DSA, MRA (MRI), CTA (CT), cerebral perfusion imaging, and electroencephalography (EEG), among others.

2.1 DSA

DSA is the gold standard for the development of a diagnosis and treatment plan before surgery in children with MMD. In addition, DSA has decisive implications for follow-up and post-surgical vascular reconstruction evaluations. During the diagnosis of childhood-onset MMD, in addition to the basic characteristics of stenosis and the occultation of the internal carotid artery and its major branches, the extensive formation of a collateral circulation bypass is also an important diagnostic factor. DSA can provide information regarding the hemodynamic mode. A collateral circulation bypass can be classified into the following four types: ① basal surface of the cerebral vascular network; ② extensive expansion of the anterior choroidal artery and the posterior pericallosal artery; ③ the ethmoidal artery vascular network; and ④ the parietal vascular network 50. When evaluating the degree of post-surgical vascular reconstruction, Matsushima et al. defined classification standards according to DSA to evaluate the formation of collateral circulation induced by vascular anastomosis. Grade A indicates that over two-thirds of the middle cerebral artery (MCA) anastomosis-induced circulation is fulfilled, grade B indicates one-third to two-thirds fulfillment, and grade C represents less than one-third fulfillment 51. Considering the special treatment parameters for children, the application of DSA also exhibits obvious drawbacks, such as invasiveness and radiation-induced harm to the body.

2.2 MRA and CTA

Even though the accuracies of MRA and CTA are not as high as that of DSA, these techniques are still extensively used in the diagnosis of MMD in children. MRA in particular has become a screening tool for the identification of high-risk MMD-affected children 52. The primary reason for this preference is that MRA causes no radiation damage in pediatric patients and achieves an ideal accuracy in diagnosis. For example, Yamada et al. examined the accuracy of MRA in the diagnosis of intracranial artery stenosis and discovered that, compared to DSA, MRA could achieve 88% accuracy in the internal carotid artery (ICA), 83% accuracy in the anterior cerebral artery (ACA), and 88% accuracy in the MCA, which suggested that the sensitivity and specificity of MRA for artery stenosis were close to 100% 53. MRA is not only suitable for the diagnosis of MMD in children, but is also applicable for both treatment and follow-up after treatment. For example, continuous MRA examinations can trace the post-surgical vascular reconstruction process. Houkin et al. used MRA to observe that an MMD vascular lesion began to degrade one month after vascular bypass surgery. Meanwhile, the diameters of the deep temporal artery and middle meningeal artery increased accordingly. All of these transitions were observed on MRA within three months after the surgery 54. The application of CTA in children with MMD is far less common than in adults, which might be due to the requirement of a contrast medium and the physical control required during the time window of image acquisition. However, compared to MRA, an advantage of CTA is the short examination time, which can be used for an emergency diagnosis of MMD in children. In addition, the sensitivity of CTA in describing the median sizes of arteries is better than that of MRA55. As with MRA, CTA is not only suitable for the diagnosis of MMD in children, it can also be used to evaluate the degree of angiogenesis after vascular bypass surgery 56.

2.3 Cerebral perfusion imaging

The cerebral blood flow volume of children with MMD is lower than that in healthy children of the same age. Additionally, the cerebral blood flow is mainly distributed in the posterior circulation, while cerebral blood flow is mainly distributed in the anterior circulation in healthy children. Therefore, the blood flow volume distribution plays an important role in the diagnosis of MMD in children 57. Currently, common clinical examinations include single-photon emission computed tomography (SPECT), positron emission tomography (PET), computed tomography (CT) perfusion, and magnetic resonance (MR) perfusion, among others. Kim et al. used (68)Ga-Arg-Gly-Asp (RGD) PET to evaluate the degree of post surgical blood flow reconstruction in pediatric MMD patients 58. Ancelet et al. determined the importance of CT perfusion and MR perfusion in evaluating disease severity and treatment efficacy 59. Additionally, cerebral perfusion imaging has become increasingly important in the diagnosis and treatment of MMD in children. For example, important cerebral perfusion pressure parameters, such as the mean transit time, cerebral blood flow, and time to peak (TTP), can be used to compare the hemodynamic variations before and after vascular reconstruction 60. For example, TJ Yun et al. found that in children with MMD, the total average TTP values were 3.35±2.53 seconds and 1.73±1.53 seconds before and after surgery, respectively. This result suggested a significant decrease in the TTP value and a remarkable improvement of cerebral blood flow after surgery, which reflects a positive outcome of the surgical treatment 61.

2.4 EEG

A hyperventilation-induced diffuse high voltage phase was observed in the EEG monitoring results for all children. This high voltage phase consisted of a single-phase slow wave characterized by a build up and termination at the end of hyperventilation. However, in children with MMD, 50% of patients demonstrated another high voltage phase after the end of hyperventilation. This high voltage phase was also a single-phase slow wave and was called the rebuild-up. This phenomenon might be caused by a decrease in the cerebral perfusion reserve, which can be considered a characteristic change in children with MMD 62,63. However, the disadvantage of EEG is that it is unable to quantify detailed indices of the cerebral perfusion reserve.

IV. Clinical symptoms of MMD in children

Maki et al. classified the clinical symptoms of MMD in children into four types: ①bleeding type; ②epileptic type; ③infarction type; and ④transient ischemic attack (TIA) type 64. In contrast to adult MMD, ischemia is often observed at the onset of MMD in children. Therefore, the most common types of MMD in children are the TIA type and the infarction type, which account for 70-80% of MMD cases in children 50,65. The infarction type is more commonly observed than the TIA type in children with MMD. The main reason is that pediatric patients cannot accurately describe TIA symptoms; thus, the diagnosis is missed 62. The ischemic damage can be classified as cortical, subcortical, and watershed type based on the location of the infarction. The watershed type is the most commonly observed type of ischemia in MMD in children, and the infarction is located in the deep watershed zone 66. HJ Cho et al. found that cortical and the watershed types were the most common types of infarctions observed in children with MMD, while the honeycomb type was the most common type in adults with MMD 67. MMD in children is also different from MMD in adults in terms of common symptoms such as headache, mental decline or degeneration, hypertension, and temporary or permanent blindness.

1. Headache

Headache is the most commonly observed symptom in children with MMD and is the most non-specific symptom. In addition, no effective clinical treatment has been discovered for this condition. A previous study revealed that possible reasons for headache occurrence might be cerebral hypoxia or an expanded pia mater in the collateral circulation, which could stimulate epidural pain receptors 13. The treatment efficacy of this type of pain is often unsatisfactory. HJ Seol et al. evaluated 204 children with MMD and discovered that 25% of children with MMD presented headache symptoms. After indirect surgery, over 50% of patients still exhibited headache symptoms at least 12 months later 68.

2. Mental decline or degeneration

Mental decline is a specific symptom of MMD in children and is mainly due to the lack of cerebral perfusion over a long time period. Soriani et al. performed a 14-month follow-up study on MMD in children less than four years old and discovered that all of the children suffered from irreversible mental decline 69. Kurokawa et al. found that four years after MMD onset, 92% of pediatric patients had normal intelligence levels. However, five to nine years later, only 40% of patients remained at normal intelligence levels, and after 10-15 years, only 33% of pediatric MMD patients remained at normal levels 70. It can be concluded that MMD has tremendous effects on the intelligence of children.

3. Hypertension

Hypertension is another common clinical symptom of children with MMD. A possible cause of this symptom could involve insufficient cerebral blood flow perfusion, resulting in a compensatory higher blood pressure in an effort to maintain a sufficient cerebral blood supply, which manifests as hypertension. Long-term hypertension can induce renal artery stenosis, which affects 10% of children with MMD 71.

4. Temporary or permanent blindness

Blindness in affected MMD patients is primarily a result of posterior circulation ischemia. Clinical reports that discuss this symptom are limited, but it is a prominent clinical manifestation of MMD in children. Specifically, the symptom appears as visual field hemianopia and a visual field defect. Miyamoto et al. evaluated 178 MMD patients and found that 48 patients had visual lesions; 79.1% of these patients were pediatric patients with MMD 72.

5. Other symptoms

In addition to common clinical symptoms, such as those discussed above, many non-specific clinical symptoms have also been observed, including hemiplegia, general paresis of the insane, loss of sensation, aphasia, and cognitive impairment, and the mechanisms might be related to ischemia in the frontal, parietal, and temporal lobes64. DS Kim et al. found that hemiplegia affected 86.4% of children with MMD 73. Hsu YH et al. discovered that cognitive impairment was related to temporal lobe lesions in children with MMD 74. In addition, normal behaviors, including hyperventilation, crying, and coughing, are also suspected to be MMD-related symptoms in children 64.

V. Treatment of MMD in children

It is generally agreed that active surgical treatment should be provided for children with MMD. The purpose of surgical treatment is to establish external carotid artery collateral circulation by surgical means to prevent and treat ischemic damage in cerebral tissues 75. Based on a previous report, the incidence of stroke in symptom-free MMD children is 3.2% each year. If no active surgical treatment is applied, 37% of patients exhibit symptoms related to nervous system damage, and 3% of patients will die, which suggests the necessity of active surgical treatment in children with MMD 76. Although conservative treatment is not the major treatment plan for MMD in children, it can be used as an auxiliary approach to surgical treatment. For example, the calcium channel blocker nicardipine exhibited a positive effect in improving the hemodynamics of children with MMD by optimizing the collateral circulation to prevent ischemia 77. However, some medications, including corticosteroids, low-molecular-weight dextran, and antiplatelet drugs, have shown no significant effects on MMD in children based on clinical progression monitoring and imaging analysis78. Surgical treatment is currently an effective method to treat MMD in children and includes direct and indirect surgeries.

1. Direct surgery

Direct surgery is primarily performed to directly anastomose the STA and MCA. To increase the success rate of this procedure, the cerebral blood flow volume is tested and is the primary factor when selecting the brain surface artery branches of the MCA 79. However, the current surgical success rate in children with MMD is not ideal for two major reasons: ①the vessels on the cerebral surface are slender and fragile in children, and as a result, direct vascular reconstruction is much more difficult in children than in adults. ② Due to the temporary blockage of the blood supply at the brain surface by the artery that is causing insufficient cerebral perfusion, cerebral tissue ischemia and infarction may occur and exacerbate the condition 11. Various complications are often observed in many pediatric patients after surgery and result in poor prognoses. For example, Hayashi et al. found that some MMD pediatric patients showed various degrees of short-term deterioration of the nervous system after STA-MCA procedures 80. Additionally, Robertson et al. observed blockage in vessels near the MCA after performing STA-MCA procedures in children with MMD 81. These results might be due to the shift of the watershed zone after vascular reconstruction. Yoshida et al. completed a 78-month follow-up study on children with MMD after STA-MCA procedures and discovered that the STA was slender and thinner than before the surgery. Therefore, it can be inferred that, although direct surgery can achieve faster treatment efficacy than indirect surgery, these changes in the STA would affect the establishment of effective cerebral collateral circulation and could result in a reduced cerebral blood supply from the external carotid artery 82. Ishii et al. found that only a limited area showed improvement in the cerebral blood flow after STA-MCA surgery. Although TIA symptoms could be controlled in some children with MMD after direct surgery, their mental disorders were exacerbated. This issue might be related to the fact that the frontal lobe circulation was not reconstructed after surgery 83. Therefore, despite the significant effect of STA-MCA surgery in children, it is not able to completely alter the ischemic conditions in children with MMD and improve their prognosis.

2. Indirect surgery

The efficacy of indirect surgery in children with MMD is better than that in adults 84. Takanashi et al. reported that, after indirect surgery, almost all children with MMD successfully established collateral circulation, while only 50% of adult MMD patients achieved this effect 50. Compared to direct surgery, the advantages of indirect surgery include less trauma, easier technical requirements, and shorter surgical time, while a disadvantage is the longer period required for vascular reconstruction 85. Therefore, indirect surgery is not recommended for emergencies that require immediate blood circulation improvement. For example, Miyamoto et al. suggested that indirect surgery is not recommended for treating MMD children with frequent TIA because it cannot rapidly accomplish vascular reconstructions 86. Direct surgery can only improve the cerebral circulation in the area of the vascular reconstruction, while indirect surgery can improve the cerebral circulation on a relatively larger scale. Therefore, indirect surgery is extensively applied in children with MMD. Thines et al. showed that indirect surgery was favored in children with MMD due to its simplicity and good clinical results. In contrast, direct or preferentially combined surgery is more effective in adults with MMD for preventing the recurrence of ischemic or hemorrhagic stroke 85. Currently, commonly used indirect surgical procedures in clinical practice include encephalomyosynangiosis (EMS), encephalo-duro-arterio-synangiosis (EDAS), encephalo-duro-myo-synangiosis (EDMS), encephalo-duro-arterio-myo-synangiosis (EDAMS), multiple burr hole surgery (MBHS), and transplantation of the greater omentum. However, there is no clinical evidence demonstrating which one of the above techniques is more effective in treating MMD in children 84,87.

2.1 EMS, EDAS, EDMS and EDAMS

EMS surgery involves attaching the temporal muscle directly onto the surface of the cerebral cortex to establish collateral circulation and is the first-line indirect surgical procedure 87. EDAS involves freeing the superficial temporal artery, maintaining its complete patency, and then attaching it onto the brain surface. EDMS and EDAMS combine EMS and EDAS procedures to further improve these techniques. In theory, both are indirect vascular reconstruction procedures. In particular, EDAMS involves a variety of anatomical structures, such as the external dura mater, with its rich blood supply, the galea aponeurotica flap, and the temporal muscle and its deep temporal artery to promote postoperative coronary collateral circulation 88. For EMS, EDAS, EDMS, and EDAMS, vascular reconstruction is restricted at the parietal center. The reason for this restriction is that the anterior branches of the STA are on the forehead and cannot participate in vascular reconstruction. Only the posterior branches of the STA are used in these procedures. Touho et al. suggested that the parietal branches of the STA have a limited blood supply area after surgery, which could not cover an extensive cortical functional area 89. Due to the limitations discussed above, these surgical techniques are continuously being improved in clinical practice to increase the success rates of post-surgical vascular reconstruction procedures. Touho et al. discovered that the temporal muscle (especially calcified and thickened temporal muscle) oppressed the corresponding cerebral tissues and induced brain ischemic symptoms during an EMS procedure. Therefore, the authors suggested prioritizing the scalp artery and the subcutaneous tissue of the corresponding collateral vessels to effectively treat mild hemiplegia and aphasia caused by ischemia in the MCA blood supply area. This procedure also improved the treatment of complications such as paraparesis and urine incontinence caused by ischemia in the ACA blood supply area 90. Yoshida et al. suggested an incision in the arachnoid membrane during surgery. The reason for this step was that the incision could activate the establishment of collateral circulation, particularly by promoting anastomosis between the external carotid artery system and the brain's surface blood vessels 91. Baaj et al. recommended overturning the dura mater near the middle meningeal artery because anastomosis was easily achieved between the exterior of the dura mater near the middle meningeal artery and the cerebral cortex 92.

2.2 Other surgeries

Pia mater anastomosis and MBHS. Pia mater anastomosis involves attaching the adventitia of the STA to the exposed pia mater after cutting open the dura mater and the arachnoid membrane 93. The arachnoid membrane is incised during the surgery, and the dura mater is not blocked. However, the incidence of cerebrospinal leakage is extremely low, and the post-surgical effect is adequate 75. For example, Robertson et al. performed the above surgery on 13 children with MMD, and 10 patients showed stabilized or improved conditions in the post-surgical follow-up 94. MBHS involves drilling the skull, followed by an incision in the dura mater and opening of the arachnoid membrane and pia mater. The periosteum is then attached to the surface of the cerebral cortex. This surgery is an auxiliary procedure to STA-MCA, EMS, and EDAM procedures, among others. For example, Sainte-Rose et al. performed MBHS on 24 hemispheres of 14 children with MMD, resulting in no exacerbated ischemia outcomes and only one case with complications 95. Transplantation of the greater omentum. This surgery involves transplanting the abdominal omentum to the surface of the cerebral cortex. The transplantation procedure directly anastomoses the gastroepiploic vessels in the omental free flap with the cerebral superficial temporal vessels. This procedure is rarely used in clinical practice and is suitable for MMD in children for whom direct and indirect surgeries are not possible 96. The characteristics of this surgery include effectively treating ischemia in ACA and PCA blood supply area-induced MMD in children, while most procedures (e.g., STA-MCA, EMS, EDAS, EDMS, and others) can only treat ischemia in the MCA blood supply area-induced MMD in children97. In recent years, Navarro et al. have improved the success and post-surgical complication rates of this procedure using laparoscopy. They performed laparoscopic omental transplantation in three children with MMD, resulting in improved ischemic conditions within three months after the surgery. One year later, MRI examinations revealed significant enhancements in cerebral perfusion, and no new ischemic lesions were observed 96.

VI. Prognosis of MMD in children

Evidence-based medicine has demonstrated that active surgical treatment for MMD in children can effectively increase the quality of life and reduce the risk of ischemic diseases. These improvements are primarily due to improved cerebral hemodynamics in patients. In contrast, conservative treatments resulted in poor prognoses in children with MMD 74. For example, Imai H et al. examined 48 children with MMD who underwent surgical procedures and found that perioperative complications were observed in four of 48 patients. Moreover, except for one child with recurrent transient ischemic attacks, the patients showed excellent clinical outcomes98. Guzman et al. performed 168 surgeries on 96 children with MMD (76.2% STA-MCA surgeries and 23.8% involving other indirect surgeries). Thirty days after surgery, only three patients had poor prognoses, whereas the other 93 patients had excellent prognoses 99. Fujimura et al. performed STA-MCA surgery on 17 children with MMD; 14 patients had good prognoses (82.4%), and none of the patients showed permanent functional nerve impairments 100. Ross et al. performed EDAS on six children with MMD and reported the results from their 0.5- to 9-year follow-up periods. None of the patients exhibited evidence of deterioration due to the disease 64. In conclusion, whether the surgical treatment is direct or indirect, the significance of active surgical treatment for children with MMD is affirmative. In most cases, surgical treatment results in satisfactory efficacy. Compared to adult patients, children with MMD can realize a good prognosis if early diagnosis and early active surgical treatment are achieved.

VII. Outlook of MMD in children

For childhood-onset MMD, early diagnosis and treatment are crucial. However, the incapability of self-description in pediatric patients produces considerable difficulties for an early diagnosis. Therefore, based on the pathogenesis of MMD in children, the development of objective diagnostic approaches is extremely important. Considering the special anatomical and hemodynamic properties of children with MMD, the choice of a surgical plan and the judgment on prognosis are also important after surgery. Meanwhile, the application of precision instruments and monitoring hemodynamics during surgery can greatly assist in increasing the surgical success rate. In summary, increasing the cure rate of MMD in children requires long-term clinical studies and practice, which will, in turn, require the contributions and efforts of numerous excellent neurological surgeons.
  94 in total

1.  Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study.

Authors:  Hao Li; Zheng-Shan Zhang; Zhen-Nan Dong; Mai-Juan Ma; Wei-Zhong Yang; Cong Han; Ming-Mei Du; Yun-Xi Liu; Hong Yang; Wei Liu; Lian Duan; Wu-Chun Cao
Journal:  Stroke       Date:  2011-02-24       Impact factor: 7.914

2.  Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey.

Authors:  K Wakai; A Tamakoshi; K Ikezaki; M Fukui; T Kawamura; R Aoki; M Kojima; Y Lin; Y Ohno
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

Review 3.  Moyamoya disease in children.

Authors:  David M Ibrahimi; Rafael J Tamargo; Edward S Ahn
Journal:  Childs Nerv Syst       Date:  2010-07-04       Impact factor: 1.475

4.  Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2007-12-08       Impact factor: 1.475

5.  Moyamoya phenomenon after radiation for optic glioma.

Authors:  J R Kestle; H J Hoffman; A R Mock
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

6.  Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.

Authors:  M Hojo; M Hoshimaru; S Miyamoto; W Taki; I Nagata; M Asahi; N Matsuura; R Ishizaki; H Kikuchi; N Hashimoto
Journal:  J Neurosurg       Date:  1998-10       Impact factor: 5.115

7.  A novel susceptibility locus for moyamoya disease on chromosome 8q23.

Authors:  Kaoru Sakurai; Yasue Horiuchi; Hidetoshi Ikeda; Kiyonobu Ikezaki; Takashi Yoshimoto; Masashi Fukui; Tadao Arinami
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

8.  Moyamoya syndrome associated with severe iron deficiency anemia in a young child.

Authors:  Shyam S Meena; Teliki V Ramkumar; Suvasini Sharma; Satinder Aneja; Atin Kumar
Journal:  Pediatr Hematol Oncol       Date:  2012-05       Impact factor: 1.969

9.  Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.

Authors:  Raphael Guzman; Marco Lee; Achal Achrol; Teresa Bell-Stephens; Michael Kelly; Huy M Do; Michael P Marks; Gary K Steinberg
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

10.  Electroencephalography in pediatric moyamoya disease: reappraisal of clinical value.

Authors:  Anna Cho; Jong-Hee Chae; Hun Min Kim; Byung Chan Lim; Hee Hwang; Yong Seung Hwang; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang; Byung-Kyu Cho; Ki Joong Kim
Journal:  Childs Nerv Syst       Date:  2013-08-13       Impact factor: 1.475

View more
  12 in total

1.  Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.

Authors:  Sherif Rashad; Miki Fujimura; Kuniyasu Niizuma; Hidenori Endo; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

2.  A rare case of pediatric moyamoya disease with reversible white matter lesions in a 3-year-old Chinese girl.

Authors:  Shi-Jun Li; Jie Xiong; Yu He; Yang-Yang Xiao; Ding-An Mao; Li-Qun Liu
Journal:  Childs Nerv Syst       Date:  2019-11-10       Impact factor: 1.475

Review 3.  Paediatric arterial ischemic stroke: acute management, recent advances and remaining issues.

Authors:  Margherita Rosa; Silvana De Lucia; Victoria Elisa Rinaldi; Julie Le Gal; Marie Desmarest; Claudio Veropalumbo; Silvia Romanello; Luigi Titomanlio
Journal:  Ital J Pediatr       Date:  2015-12-02       Impact factor: 2.638

4.  Moyamoya disease manifested as multiple simultaneous intracerebral hemorrhages: A case report and literature review.

Authors:  Jinlu Yu; Yongjie Yuan; Wei Li; Kan Xu
Journal:  Exp Ther Med       Date:  2016-06-24       Impact factor: 2.447

5.  Bilateral Moyamoya Disease in a 2-Year-Old Pakistani Male Treated with Bilateral Encephaloduroarteriosynangiosis: A Positive Outcome.

Authors:  Shahvaiz Magsi; Adeel Khoja; Mansoor Ali Merchant Rameez; Ariba Khan; Noman Ishaque
Journal:  Case Rep Neurol Med       Date:  2016-12-22

6.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

7.  Moyamoya Vasculopathy in Indian Children: Our Experience.

Authors:  Varsha Anant Patil; Shilpa Dattaprasanna Kulkarni; Chandrashekhar E Deopujari; Naresh K Biyani; Anaita H Udwadia-Hegde; Krishnakumar N Shah
Journal:  J Pediatr Neurosci       Date:  2017 Oct-Dec

8.  Endovascular Treatment of a Patient with Moyamoya Disease and Seckel Syndrome: A Case Report.

Authors:  Aylin Gunesli; Cagatay Andic; Ozlem Alkan; Ilknur Erol; Halil Ibrahim Suner
Journal:  J Pediatr Neurosci       Date:  2018 Apr-Jun

9.  Comparison of Long-Term Effect Between Direct and Indirect Bypass for Pediatric Ischemic-Type Moyamoya Disease: A Propensity Score-Matched Study.

Authors:  Yahui Zhao; Junlin Lu; Shaochen Yu; Jiaxi Li; Xiaofeng Deng; Yan Zhang; Dong Zhang; Rong Wang; Hao Wang; Yuanli Zhao
Journal:  Front Neurol       Date:  2019-07-31       Impact factor: 4.003

10.  Angiographic study of the transdural collaterals at the anterior cranial fossa in patients with Moyamoya disease.

Authors:  Kun Hou; Guichen Li; Yunbao Guo; Baofeng Xu; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.